These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9624043)

  • 1. Use of cellular and cytokine adjuvants in the immunotherapy of cancer.
    Salgaller ML; Lodge PA
    J Surg Oncol; 1998 Jun; 68(2):122-38. PubMed ID: 9624043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine cytokine adjuvants in cancer immunotherapy.
    Pardoll DM
    Annu Rev Immunol; 1995; 13():399-415. PubMed ID: 7612229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR; Wroblewski JM
    Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell therapy in solid tumors].
    Ravaud A
    Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy: development of immunostimulatory treatments for cancer.
    Gilligan MG; Knox PG; Searle PF
    Biotechnol Genet Eng Rev; 2000; 17():497-529. PubMed ID: 11255679
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular immunotherapy of cancer].
    Kawakami Y
    Rinsho Ketsueki; 2003 Jun; 44(6):358-67. PubMed ID: 12884813
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
    Moschella F; Proietti E; Capone I; Belardelli F
    Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell therapy in renal cell carcinoma].
    Ravaud A
    Bull Cancer; 2003; 90(8-9):711-21. PubMed ID: 14609761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
    Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
    Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapy of melanoma with cytokines and lymphocytes.
    Bear HD; Hamad GG; Kostuchenko PJ
    Semin Surg Oncol; 1996; 12(6):436-45. PubMed ID: 8914208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of T lymphocytes in the immunotherapy of tumours.
    Brondz BD; Balashov KE
    Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells and cytokines in immune rejection of cancer.
    Ferrantini M; Capone I; Belardelli F
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):93-107. PubMed ID: 18054517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy.
    Alli RS; Khar A
    Indian J Biochem Biophys; 2002 Dec; 39(6):363-7. PubMed ID: 22905392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell transfer-based immunotherapies in cancer: A review.
    Gorabi AM; Hajighasemi S; Sathyapalan T; Sahebkar A
    IUBMB Life; 2020 Apr; 72(4):790-800. PubMed ID: 31633881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
    Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
    J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
    Dessureault S; Noyes D; Lee D; Dunn M; Janssen W; Cantor A; Sotomayor E; Messina J; Antonia SJ
    Ann Surg Oncol; 2007 Feb; 14(2):869-84. PubMed ID: 17103257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of antitumor immune responses by hematopoietic cytokines.
    Waller EK; Ernstoff MS
    Cancer; 2003 Apr; 97(7):1797-809. PubMed ID: 12655538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.